跳至主要内容
临床试验/CTRI/2022/10/046883
CTRI/2022/10/046883已完成4 期

A randomized control trial to assess the role of Camylofin Dihydrochloride in acceleration of active phase of labour in tertiary care hospital

il0 个研究点目标入组 114 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
114

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • primigravidas in age group of 18-35 years with gestational age of 37-40 weeks with singleton foetus in vertex presentation, in active phase of labour. (Active phase of labour- 5cm or more cervical dilatation with uterine contractions.

排除标准

  • any antenatal pregnancy complications like preeclampsia, eclampsia , suspected cephalopelvic disproportion, premature rupture of membranes, placenta previa, abruptio placenta, abnormal presentation, preterm labour, multiple pregnancy and patients requiring induction or use of any oxytocic drugs and any other medical disorders like diabetes, cardiac, renal and hepatic disorders. Known hypersensitivity to drugs will be excluded

研究者

发起方
il

相似试验